Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

906
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
906
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

841
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
841
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

4.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Features of Importance in the Nasal Exam in Rhinoplasty.

Facial plastic surgery & aesthetic medicine·2026
Same author

Carving Out Change: Women Leading in Facial Plastic Surgery.

Facial plastic surgery & aesthetic medicine·2026
Same author

Use of Augmented Reality Technology in Cosmetic Rhinoplasty: A Feasibility Study.

Facial plastic surgery & aesthetic medicine·2026
Same author

Postoperative Pain Management in Rhinoplasty: A Double Blind Randomized Controlled Trial.

Facial plastic surgery & aesthetic medicine·2026
Same author

What to Expect With Skin Cancer Reconstruction.

JAMA otolaryngology-- head & neck surgery·2026
Same author

Nationwide Analysis of Head and Neck Imaging for Bell's Palsy: Insights From Healthcare Claims.

The Laryngoscope·2025

相关实验视频

Updated: Jan 13, 2026

Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction
06:32

Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction

Published on: December 5, 2025

551

在额叶重建后持续使用阿片类药物的危险因素

Alexander J Barna1, Rahul K Sharma2, Nicole G DeSisto2

  • 1Drexel University College of Medicine, Philadelphia, PA, USA.

The Annals of otology, rhinology, and laryngology
|January 7, 2026
PubMed
概括
此摘要是机器生成的。

在额叶手术后的术后阿片类药物处方增加了持续使用阿片类药物的风险. 手术后接受阿片类药物治疗的患者患上新的持续阿片类药物使用的可能性超过三倍.

关键词:
面部重建 面部重建面部创伤可能是面部创伤.额头上的片.这是一种阿片类阿片类药物.一个脚的片.

更多相关视频

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.7K
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

11.2K

相关实验视频

Last Updated: Jan 13, 2026

Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction
06:32

Coronoid-Temporalis Pedicled Flap for Orbital Floor Defect Reconstruction

Published on: December 5, 2025

551
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.7K
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

11.2K

科学领域:

  • 整形外科 整形外科 整形外科
  • 疼痛管理 疼痛管理
  • "阿片类药物使用障碍"

背景情况:

  • 在重建外科手术中使用了带有保存的血管脚的额叶片.
  • 持续使用阿片类药物是外科手术后的一个重大问题.
  • 了解持续使用阿片类药物的风险因素对于患者护理至关重要.

研究的目的:

  • 评估早期术后阿片类药物处方与额头片重建后新的持续阿片类药物使用的发展之间的关联.
  • 为了确定在接受这种特定手术的患者中导致长期阿片类药物依赖的风险因素.

主要方法:

  • 一项利用TriNetX美国协作网络的多中心队列研究.
  • 鉴定了接受额叶翻盖重建并保留血管脚架的患者.
  • 倾向性得分匹配用于控制混变量,并计算风险比率以评估新的持续阿片类药物使用的可能性.

主要成果:

  • 总共有7214名患者最初被确定,其中2660人 (36.9%) 接受了术后阿片类药物处方.
  • 在倾向匹配后,分析了1352名患者.
  • 手术后处方阿片类药物的患者与未处方阿片类药物的患者相比,患上新的持续阿片类药物使用的风险增加了3.21倍.

结论:

  • 在额叶重建后的早期术后阿片类药物处方与发展新的持续阿片类药物使用的风险增加有关.
  • 这一发现强调了在经过额叶手术的患者在术后期谨慎使用阿片类药物处方的重要性.
  • 进一步的研究可能会探索替代性疼痛管理策略,以减轻阿片类药物依赖风险.